Aortic Endograft Market Segmentation, Scope And Forecast 2025 - 2034

Unlock 20% Off Global Market Reports Using Code ONLINE20 – Stay Informed on Trade Policies, Market Growth, and Key Disruptors

How Is the Aortic Endograft Market Growth Forecast from 2025 to 2029?
The aortic endograft market size has grown strongly in recent years. It will grow from $3.35 billion in 2024 to $3.52 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to growth in medical tourism, increasing need for aortic aneurysm management, increasing number of aortic aneurysm cases, technical success of endograft implantation, increase in the number of hospitals.

The aortic endograft market size is expected to see steady growth in the next few years. It will grow to $4.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing prevalence of abdominal aortic aneurysm, growing preference for minimally invasive endovascular procedures, rising geriatric population, advancements in stent-graft materials and configurations, introduction of new stent-graft products. Major trends in the forecast period include adoption of endovascular abdominal aortic aneurysm (AAA) repair devices, effectiveness of unibody and non-unibody aortic stent, product innovation.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13784&type=smp

Which Major Growth Factors Are Shaping the Aortic Endograft Market?
The growing prevalence of aortic aneurysms is expected to propel the growth of the aortic endograft market going forward. An aortic aneurysm is a localized and abnormal dilation or bulging of the aorta, which is the largest artery in the human body. Aortic endografts are used to treat aortic aneurysms because they are less invasive than traditional open surgery. A fabric-covered metal or polymer device is inserted through a catheter, strengthening weak aortic walls and lowering the risk of rupture. For instance, in February 2023, according to Government Digital Service, a UK-based public sector information website, around 274,800 men were offered screening, with 79.0% receiving a conclusive screen and 1,794 aneurysms being found April 2021 to March 2022. Therefore, the growing prevalence of aortic aneurysms is driving the growth of the aortic aneurysm market.

Which Segment Offers the Highest Growth Opportunities in the Aortic Endograft Market?
The aortic endograftmarket covered in this report is segmented –

1) By Product: Abdominal Aortic Grafts, Thoracic Aortic Grafts
2) By Material: Metallic Endografts, Polymeric Endografts
3) By Procedure: Open Surgical Repair, Endovascular Aneurysm Repair (EVAR)
4) By End User: Hospitals, Ambulatory Surgical Centers

Subsegments:
1) By Abdominal Aortic Grafts: Fenestrated Aortic Grafts, Branched Aortic Grafts, Conventional Aortic Grafts
2) By Thoracic Aortic Grafts: Stented Thoracic Aortic Grafts, Non-Stented Thoracic Aortic Grafts, Hybrid Thoracic Aortic Grafts

What Are the Key Industry Trends Transforming the Aortic Endograft Market?
Major companies operating in the aortic endograft market are developing innovative solutions, such as the castor-branched aortic stent graft system, to gain a competitive edge in the market. The castor-branched aortic stent graft system is a medical device used for minimally invasive repair of the aorta and aortic arch, particularly in cases of Stanford type B aortic dissection (TBAD). For instance, in August 2024, Terumo India, an India-based, a major player in medical technology, and the Indian subsidiary of Terumo Corporation, launched the TREO Stent-Graft System, an innovative solution for Endovascular Aneurysm Repair (EVAR). This advanced system is designed for the treatment of infrarenal abdominal aortic aneurysms in adults with appropriate anatomies and is the only EVAR graft to offer both suprarenal and infrarenal active fixation.

Who Are the Key Players Driving the Aortic Endograft Market?
Major companies operating in the aortic endograft market report are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., LifeTech Scientific Corporation, Altura Medical Inc., MicroVention Inc., MicroPort Scientific Corporation, CryoLife Inc., Cordis Corporation, Endologix LLC, Braile Biomédica Indústria Comércio e Representações Ltda., Nano Endoluminal S.A., Biomerics LLC, JOTEC GmbH, Lombard Medical Inc., Aptus Endosystems Inc., Lombardi SA, Cardiatis S.A., Endospan Ltd., Transcatheter Technologies GmbH

Get the full aortic endograft market report here:
https://www.thebusinessresearchcompany.com/report/aortic-endograft-global-market-report

What Are the Regional Insights for the Aortic Endograft Market Forecast?
North America was the largest region in the aortic endograft market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic endograft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company